Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 2, 2024 |
| Target | Guilong Pharmaceutical |
| Sector | Life Science |
| Buyer(s) | Trustar Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1978 |
| PE ASSETS | 8.7B USD |
| Size | Mega |
| Type | Sector Agnostic |
Trustar Capital is the private equity arm of financial services/asset manager CITIC Group. Trustar Capital separates its private equity investment activity into three groups; China, Japan, and the US. In general, Trustar looks to invest in companies with 'strong franchises', with established brands and high barriers to entry. For US-based opportunities, the firm looks to leverage its connections in China. Broad areas of interest include niche manufacturing, consumer products, and business services. The Firm does not invest in start-ups or distressed businesses. Trustar Capital is based in Hong Kong.
| Deal Context for Buyer | # |
|---|---|
| Overall | 64 of 64 |
| Sector: Life Science | 4 of 4 |
| Type: Buyout (LBO, MBO, MBI) | 24 of 24 |
| Country: China | 31 of 31 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-31 |
Mark Styler
Shibuya, Japan Mark Styler designs, develops and does retailing of women’s apparels under various brands including MERCURYDUO, EMODA, dazzlin, MURUA and Ungrid. Mark Styler was founded in 2005 and is based in Shibuya, Japan. |
Sell | - |
